Pink vs. white inhaler actuators studied for asthma symptom perception in crossover trial

This was a phase IIIb, randomized, double-blind, crossover trial conducted across 10 active centers. It enrolled 78 adult patients with moderate to severe asthma. The study compared the same medication—beclomethasone dipropionate 100 µg/formoterol fumarate 6 µg—delivered via two different pressurized metered-dose inhalers (pMDIs) that differed only in actuator color (pink versus white). The primary outcome was the change from baseline in the average visual analog scale (VAS) score for perceptions of asthma over a 14-day treatment period. Secondary outcomes included other VAS scores for symptom perception, Asthma Quality of Life Questionnaire (AQLQ) scores, measures of psychopharmacological aspects, patient device preference, and reliever medication use. No specific results for these outcomes, including effect sizes, p-values, or absolute numbers, are reported in the provided data. Safety and tolerability data, including adverse events and discontinuations, are also not reported. Key limitations include the study's exploratory nature and the absence of a prespecified primary objective. The study was funded by Chiesi Farmaceutici S.p.A. In practice, this research investigates the potential influence of non-pharmacological device characteristics (like color) on patient perception, but it does not provide clinical efficacy or safety data to inform treatment decisions.

This was a research study that looked at whether the color of an asthma inhaler might change how patients feel about their symptoms. The study included 78 adults who have moderate to severe asthma. All patients tried two inhalers that contained the exact same asthma medicine. The only difference was that one inhaler had a pink actuator (the part you press) and the other had a white one.

The main goal was to see if the color influenced patients' perceptions of their asthma symptoms and their burden, as well as which device they preferred. The study also looked at quality of life scores and how often patients used their rescue medication. This was an exploratory study, meaning it was designed to gather initial information rather than to prove a specific point.

It is important to know that this report does not include any of the actual results from the study. We do not know if patients noticed a difference between the pink and white inhalers, which one they preferred, or if there were any safety issues. The study was funded by the pharmaceutical company that makes the inhalers.

Readers should understand that this was an early, exploratory look at how device appearance might affect patient experience. It does not provide any information on whether one inhaler works better or is safer than the other. The findings, when they become available, will need to be considered carefully because the study's main focus was on perception, not on proving the medicine's clinical effectiveness.